Sulforaphane
- Generic Name
- Sulforaphane
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C6H11NOS2
- CAS Number
- 142825-10-3
- Unique Ingredient Identifier
- GA49J4310U
- Background
Sulforaphane is under investigation for the treatment of Autism Spectrum Disorder. It is a naturally occurring isothiocyanate found in high concentration in a variety of broccoli.
- Associated Conditions
- -
- Associated Therapies
- -
Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder
Phase 2
Completed
- Conditions
- Autism Spectrum DisorderAutistic DisorderNeurodevelopmental DisorderChildhood Developmental Disorders, Pervasive
- Interventions
- Drug: SulforaphaneDrug: Placebo
- First Posted Date
- 2016-09-21
- Last Posted Date
- 2020-06-04
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 48
- Registration Number
- NCT02909959
- Locations
- 🇺🇸
Carolina Institute for Developmental Disabilities, University of North Carolina School of Medicine, Carrboro, North Carolina, United States
Clinical Trial With Broccoli Sprout Extract to Patients With Type 2 Diabetes
Phase 2
Completed
- Conditions
- Diabetes Mellitus, Non-Insulin-Dependent
- Interventions
- Drug: PlaceboDrug: sulforaphane
- First Posted Date
- 2016-06-15
- Last Posted Date
- 2022-01-19
- Lead Sponsor
- Anders Rosengren, MD PhD
- Target Recruit Count
- 103
- Registration Number
- NCT02801448
Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism
Phase 2
Active, not recruiting
- Conditions
- AutismAutistic DisorderAutism Spectrum DisorderAutistic Behavior
- Interventions
- Drug: PlaceboDrug: Sulforaphane
- First Posted Date
- 2016-02-09
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 48
- Registration Number
- NCT02677051
- Locations
- 🇺🇸
Rutgers University - Staged Research Building, Piscataway, New Jersey, United States
Sulforaphane Treatment of Children With Autism Spectrum Disorder (ASD)
- First Posted Date
- 2015-09-28
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- University of Massachusetts, Worcester
- Target Recruit Count
- 60
- Registration Number
- NCT02561481
- Locations
- 🇺🇸
University of Massachusetts Medical School, Worcester, Massachusetts, United States
Sulforaphane in Treating Patients With Recurrent Prostate Cancer
Phase 2
Completed
- Conditions
- Recurrent Prostate CancerAdenocarcinoma of the Prostate
- Interventions
- First Posted Date
- 2010-10-25
- Last Posted Date
- 2017-04-28
- Lead Sponsor
- OHSU Knight Cancer Institute
- Target Recruit Count
- 20
- Registration Number
- NCT01228084
- Locations
- 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath